Initial Experience with New High Powered 120 W Holmium for Vaporization of the Prostate


Holmium laser vaporization of the prostate (Holvap) is a minimally invasive treatment option available for men with urinary obstruction secondary to benign prostatic hyperplasia (BPH). Recently, a new 120 W high powered holmium laser has been approved to treat symptomatic prostatic obstruction (Lumenis Ltd). We present our early experience with the use of this laser. Prostatic configuration, uroflow patterns, post void residuals, and subjective AUA symptom score measurements were obtained and compared before and after treatment.

Read a Commentary by Marc Beaghler, MD

Written by: 
Marc Beaghler, Mark Leo, J’aime Gass, Jordon March, Sariely Sandoval and Alex Wonnaparhown

Author Information:
University of Nevada and San Buenaventura Community Hospital, USA

Beaghler M, Leo M, Gass J, March J, Sandoval S, et al. (2017) Initial Experience with New High Powered 120 W Holmium for Vaporization of the Prostate. Urol Nephrol Open Access J 4(2): 00119. DOI:10.15406/unoaj.2017.04.00119

  1. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, et al. (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5): 1793-1803.
  2. Tan AH, Gilling PJ, Kennett KM, Fletcher H, Fraundorfer MR (2003) Long term results of high-power holmium laser vaporization (ablation) of the Prostate. BJU Int 92(7): 707-709.
  3. Moody JA, Lingeman JE (2001) Holmium laser enucleation for prostate adenemoa greater than 100 gm: comparison to open prostatectomy. J Urolo 165(2): 459-462.
  4. Lee SW, Choi JB, Lee KS, Kim TH, Son H, et al. (2013) Transurethral procedures for lower urinary tract symptoms from benign prostatic enlargement: a quality and meta-analysis. Int Neruouol J 17(2): 59-66.
  5. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, et al. (2010) A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with one year follow-up. BJU Int 105(7): 964-969.
  6. Teng J, Zhang D, Li Y, Yin L, Wang K, et al. (2013) Photoselective vaporization with the green light vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systemic review and meta-analysis. BJU Int 111(2): 312-323.
  7. Mottet N, Anidjar M, Bourdon O, Louis JF, Teillac P, et al. (1999) A randomized Comparision of transurethral electroresection and holmium: Yag laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 13(2): 227-230.
  8. Delvecchio FC, Preminger GM (2000) Endoscopic management of urologic disease with the holmium laser. Current Opinion in Urology 10(3): 233-237.
  9. Kumar A, Vasudeva P, Kumar N, Nanda B, Jha SK, et al. (2013) A prospective randomized comparative study of monopolar and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: a single center experience. J Endourol 27(10): 1245-1253.
  10. Grasso M (1996) Experience with the holmium laser as an endoscopic lithotrite. Urology 48(2): 199-206.
  11. Beaghler M, Poon M, Ruckle H, Stewart S, Weil D (1998) Complications employing the holmium: YAG laser. J Endourol 12(6): 533-535.
email news signup